Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir among COVID-19 inpatients during Hong Kong’s Omicron BA.2 wave: an observational study | medRxiv

Data Availability

The clinical outcome data were extracted from the Hospital Authority database in Hong Kong and vaccination records were extracted from the eSARS data provided by the Centre for Health Protection. Restrictions apply to the availability of these data, which were used under license for this study.

View the discussion thread.

Posted May 20, 2022.

Supplementary Material

Subject Area

Pharmacology and Therapeutics

Subject Areas

All Articles

Addiction Medicine (399)
Allergy and Immunology (708)
Anesthesia (201)
Cardiovascular Medicine (2923)
Dentistry and Oral Medicine (333)
Dermatology (249)
Emergency Medicine (439)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1033)
Epidemiology (12723)
Forensic Medicine (12)
Gastroenterology (827)
Genetic and Genomic Medicine (4571)
Geriatric Medicine (417)
Health Economics (729)
Health Informatics (2913)
Health Policy (1069)
Health Systems and Quality Improvement (1075)
Hematology (387)
HIV/AIDS (924)
Infectious Diseases (except HIV/AIDS) (14090)
Intensive Care and Critical Care Medicine (845)
Medical Education (423)
Medical Ethics (115)
Nephrology (468)
Neurology (4341)
Nursing (235)
Nutrition (637)
Obstetrics and Gynecology (802)
Occupational and Environmental Health (734)
Oncology (2264)
Ophthalmology (643)
Orthopedics (258)
Otolaryngology (324)
Pain Medicine (278)
Palliative Medicine (83)
Pathology (500)
Pediatrics (1196)
Pharmacology and Therapeutics (504)
Primary Care Research (495)
Psychiatry and Clinical Psychology (3743)
Public and Global Health (6925)
Radiology and Imaging (1524)
Rehabilitation Medicine and Physical Therapy (899)
Respiratory Medicine (915)
Rheumatology (437)
Sexual and Reproductive Health (443)
Sports Medicine (385)
Surgery (486)
Toxicology (60)
Transplantation (210)
Urology (179)